Biological Drug Development in the Pharmaceutical Industry

3 Credits

Provides the basis for a deeper understanding of the development of biological drug products (E.g., Cell Gene Therapies) from pre-clinical development through IND submission in the pharma biotech industries as well as an overview of the QA/QC regulatory considerations that are needed for successful FDA filing.